stonks

Great new BC treatments available but still w/ cardiac effects. "Taking away these cardiac effects could allow more and more [patients with] cancer to be getting life-saving therapies.” #AVCT: pre|CISION® *Eliminates* the Severe Cardiac Toxicity of Doxorubicin TNBC data H1 ⌛️

@RAH00084 😂

Who needs RNS when you have @JStonker AVA6️⃣1️⃣0️⃣3️⃣ now recruiting. Brilliant news. #AVCT

Clinical Trials just updated - AVA6103 now recruiting in Texas and Virginia 🙌🏼 clinicaltrials.gov/study/NCT07454… #AVCT

"There's an incredible amount of interest in AVA6103... the company's strategy at this point is to protect this asset until we have sight of the initial human data, such is its value." #AVCT July 2025. FIH any minute now ⏳

@sandyradders Cheers Sandy 🙏🏼 long list of BP speakers and attendees at this event, Avacta in great company ukbiotechday.org/speakers.html

@JStonker Many thanks Stonks for all the great #AVCT research you share. It is very much appreciated.

More #AVCT publicity - "Tackling undruggable targets - Innovation approaches and success stories" ukbiotechday.org/agenda.html linkedin.com/posts/ukbiotec… #AVCT

Avacta slipping in a secret third abstract. Never a dull day as an #AVCT shareholder. abstractsonline.com/pp8/#!/21436/p…

#AVCT's dual payload abstract just published too abstractsonline.com/pp8/#!/21436/p…

#AACR26 #AACR2026 abstract now available for AVA6103 abstractsonline.com/pp8/#!/21436/p… #AVCT

AVA6103 newly listed on the World Health Organisation's International Clinical Trials Registry trialsearch.who.int/Trial2.aspx?Tr… #AVCT

And again markets.businessinsider.com/news/stocks/av… #AVCT

Newswire story getting picked up this morning firstwordpharma.com/story/7138719 #AVCT

Some very pertinent AACR sessions already confirmed, as AVA6103 begins trials in pancreatic ductal adenocarcinoma. Panellists include MSKCC biologist with focus on pancreatic TME and related stromal biology. abstractsonline.com/pp8/#!/21436/s… #AVCT

SB removed from the leadership page altogether and FW moved into the CSO spot - before and after avacta.com/about/leadersh… #AVCT

A lot of updates this morning - SB replaced as BD contact, two assets in Phase 1 on the pipeline progress chart and a new 'about' page. #AVCT

"Extremely excited" 🙌🏼 #AVCT

New paper co-authored by W Tap, studying T-DXd in an 'ultrarare' STS. Results good - "favorable anticancer activity with minimal toxicity", however AEs include grade 3 febrile neutropenia, transaminitis, thrombocytopenia. All eyes on AVA6103 👀 ascopubs.org/doi/10.1200/OA… #AVCT

SAB members/affiliates W Tap, C Braconi, R Metcalf, R Jones and A Napolitano on multiple posters @ ESMO Sarcoma and Rare Cancers Congress, underway now Surprised #AVCT didn't go for this one - it sounds absolutely ideal. Maybe saving news for elsewhere? cslide.ctimeetingtech.com/sarcoma2026/at…

Great promise for sure. #AVCT